Medplus Health Services Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27
Updated: 7 Oct 2026 • 9:12 am
Posted by:
Medplus Health Services Rs 651.45 (6 Oct 2026 close). 52-week range Rs 640.10 to Rs 1,022.20. Q1 FY27 revenue Rs 1,880 cr, up 22%; profit Rs 33 cr, down 22%.
Quick Answer
The Medplus Health Services share price target for 2026 is Rs 624 to Rs 744, which is between 4 percent below and 14 percent above the last close of Rs 651.45, with bull and bear cases of Rs 930 to Rs 1,054 and Rs 330 to Rs 390. Medplus Health Services reported Q1 FY27 consolidated revenue up 21.8 percent to Rs 1,879.6 crore but profit down 21.7 percent to Rs 33.17 crore, with operating EBITDA margin at 3.5 percent against 4.7 percent a year ago. The stock fell 17.8 percent on 22 July to a 52-week low after the results, the chain has 5,476 stores after adding 146, and the shares trade at 37 times earnings against an industry average of 64 times. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.
The Medplus Health Services share price target for 2026 is Rs 624 to Rs 744 in the Univest base case, with the stock at Rs 651.45 at the 6 October 2026 close. That is 36.3 percent below its 52-week high of Rs 1,022.20 and 1.8 percent above its 52-week low of Rs 640.10, and the stock moved down 16.9 percent over the past year. Medplus Health Services runs one of India's largest pharmacy chains with 5,476 stores, a private label range and a diagnostics arm. Debt to equity is 0.72 and the company pays no dividend.
Three things changed since the last update: Q1 FY27 results on 21 July showed profit down 22 percent, the stock fell 17.8 percent the next day, and franchise stores made up 131 of the 146 net additions. This Medplus Health Services stock analysis covers the Medplus Health Services share price today, the Medplus Health Services share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Medplus Health Services buy or sell view.
Click Here – Get Free Investment Predictions
What Is the Medplus Health Services Share Price Target for 2026?
The 2026 target for Medplus Health Services shares is Rs 624 to Rs 744 in the Univest base case, which is -4.2% to +14.2% against the last close. The bull case is Rs 930 to Rs 1,054 and the bear case is Rs 330 to Rs 390. Nomura maintained a Buy rating on Medplus Health Services after the Q1 FY27 results, according to media reports, though the target price was not confirmed in the sources we track. Analyst consensus is used as a cross-check, not as the base.
Medplus Health Services Share Price Target Scenarios: Bull Case, Base Case and Bear Case
| Scenario | FY28E EPS | Target Multiple | Price Target (Rs) | Move vs Rs 651.45 |
|---|---|---|---|---|
| Bull Case | Rs 31 | 30x to 34x | 930 to 1,054 | +42.8% to +61.8% |
| Base Case | Rs 24 | 26x to 31x | 624 to 744 | -4.2% to +14.2% |
| Bear Case | Rs 15 | 22x to 26x | 330 to 390 | -49.3% to -40.1% |
FY28 EPS of Rs 24 in the base case compares with trailing EPS of Rs 17.52 and assumes revenue growth near 18 percent with margin recovering as new stores mature. Retail chains trade at premium multiples for growth, and the stock trades at about 27 times the base estimate. The PE multiple used for each case is shown in the table, and the EPS estimate is a Univest assumption, not company guidance. Those assumptions set the Medplus Health Services share price target range around the current price.
Medplus Health Services Company Overview and Share Price Today as of 6 October 2026
Medplus Health Services share price today is Rs 651.45 on the NSE at the 6 October 2026 close, before the market opens on 7 October. The market capitalisation is Rs 7,810 crore, and the stock trades at 37 times earnings against an industry average of 63.7 times. The Univest base case Medplus Health Services share price target of Rs 624 to Rs 744 is -4.2% to +14.2% from here. The table below sets out the key numbers behind the Medplus Health Services share price target.
| Parameter | Value | Context |
|---|---|---|
| NSE Ticker | MEDPLUS | BSE code 543427 |
| Sector | Pharmacy retail | Per Univest sector classification |
| Last Close (NSE) | Rs 651.45 | 6 Oct 2026 close |
| 52-Week High | Rs 1,022.20 | CMP is 36.3% below |
| 52-Week Low | Rs 640.10 | CMP is 1.8% above |
| 1-Year Return | About -17% | Weekly close Rs 784.2 on 10 Oct 2025 to Rs 651.45 |
| Market Capitalisation | Rs 7,810 crore | Small cap pharmacy chain |
| Trailing P/E | About 37.1x | Industry P/E about 63.74x |
| P/B Ratio | About 3.95x | Book value Rs 164.43 per share |
| EPS (TTM) | Rs 17.52 | Trailing twelve months |
| Return on Equity | About 11.1% | Debt to equity 0.72 |
| Dividend Yield | Nil | No dividend |
| 12-Month Target (Base Case) | Rs 624 to Rs 744 | Univest base case |
| Bull Case | Rs 930 to Rs 1,054 | +42.8% to +61.8% |
| Bear Case | Rs 330 to Rs 390 | -49.3% to -40.1% |
Track live price, fundamentals and results for Medplus Health Services on the Univest Screener.
How Did Medplus Health Services Perform in Q1 FY27?
Medplus Health Services reported Q1 FY27 consolidated revenue from operations of Rs 1,879.6 crore, up 21.8 percent from Rs 1,542.6 crore, and consolidated profit of Rs 33.17 crore, down 21.7 percent from Rs 42.34 crore. Operating EBITDA fell to Rs 65.1 crore from Rs 72.8 crore. Together these Q1 FY27 numbers anchor the Medplus Health Services share price target.
| Metric | Q1 FY27 | Context |
|---|---|---|
| Consolidated Revenue | Rs 1,879.6 crore | Up 21.8% YoY |
| Consolidated Profit | Rs 33.17 crore | Down 21.7% from Rs 42.34 crore |
| Operating EBITDA Margin | 3.5% | Against 4.7% a year ago |
| Gross Margin | 24.5% | Against 26.1% a year ago |
| Store Count | 5,476 | 146 net additions; 131 franchise |
| Older Store Productivity | 94% of sales | Stores over 12 months; 10.4% store EBITDA margin |
Management kept its FY27 target of 800 net new stores and put discretionary capex on hold. Wage hikes and new warehouse staff will weigh on costs in coming quarters, and the company announced a Rs 155 crore investment plan in Telangana. The FY27 outlook from management is the main input for these estimates. These numbers sit behind every range in the scenario table above, so they anchor the Medplus Health Services share price target.
Why Is Medplus Health Services Share Price Down 36 Percent From Its High?
Medplus Health Services shares are about 36 percent below the Rs 1,022.20 high of the week of 18 May 2026, when they rallied on Q4 results. The stock fell 10 percent in the week of 20 July after the Q1 FY27 profit decline and touched Rs 653.
It hit a 52-week low of Rs 653.80 on 22 July, down 17.8 percent in one session on volume of 38 lakh shares in the week. The stock has drifted lower since and closed at Rs 651.45, with the low of Rs 640.10 on 5 October. The Medplus Health Services share price target scenarios below account for that move.
Key Catalysts for the Medplus Health Services Share Price Target in 2026
4 catalysts matter most for the Medplus Health Services share price target, and sector tailwinds in Pharmacy retail are part of the case. Together they decide whether the base case is reached.
1. Store Growth
The chain targets 800 net new stores in FY27 after adding 146 in Q1. Stores over 12 months old generate 94 percent of pharmacy sales. If it plays out, the Medplus Health Services share price target moves toward the top of the base range.
2. Mature Store Margin
Mature stores earn a 10.4 percent store-level EBITDA margin. As new stores age, group margin should rise. Strength here would support the upper end of the Medplus Health Services share price target.
3. Pricing and Fee Changes
Management is changing pricing and fees to support profit. Better pricing would lift gross margin from 24.5 percent. Delivery on this point keeps the Medplus Health Services share price target on track.
4. Franchise Model
Franchise stores are about 5 percent of pharmacy revenue and 131 of the 146 new stores. The model needs less capital but is still being refined. Better news here would lift the Medplus Health Services share price target toward the bull case.
What Are the Key Risks to the Medplus Health Services Share Price Target?
The main risks are margin pressure, cost inflation, slow private label growth and a premium multiple. Each can pull the Medplus Health Services share price target lower.
Margin Pressure
Operating EBITDA margin fell to 3.5 percent. More start-up costs from new stores would hold profit down. If it materialises, the Medplus Health Services share price target would slip toward the bear case.
Cost Inflation
Wage hikes and new warehouse staffing will weigh more fully in coming quarters. Management has flagged this. This is the main downside risk to the Medplus Health Services share price target.
Slow Private Label Growth
Private label pharma grew only 2 percent against 20 percent for branded pharma. Weak private label hurts gross margin. A worsening here would cut the Medplus Health Services share price target toward the low end of the range.
Premium Multiple
The stock trades at 37 times earnings and 4 times book value. A bear case EPS of Rs 15 at 22 times would put the price near Rs 330. Watch it closely, because it can pull the Medplus Health Services share price target lower quickly.
Medplus Health Services Stock Analysis: Support and Resistance Levels for the Share Price Target
Medplus Health Services stock analysis on weekly charts shows a range of Rs 640 to Rs 677 since mid-September, with the stock at the lower end.
The first support level is Rs 640 to Rs 645, the lows of the weeks of 5 October, 28 September and 14 September. Below that there is no weekly support, as Rs 640.10 is the 52-week low.
The first resistance level is Rs 655.55 to Rs 661.75, the highs of the weeks of 5 and 28 September. Above that, Rs 669 to Rs 677 marks the September highs and Rs 691 to Rs 695 marks the August highs. These levels come from weekly price action, are not trade recommendations, and frame the near-term Medplus Health Services share price target.
Medplus Health Services Share Price Target 2026, 2027 and 2030: Short, Medium and Long Term
Short-Term Medplus Health Services Share Price Target (3 to 6 Months)
In the near term the stock is likely to trade between Rs 640 and Rs 677, from the 52-week low to the high of the week of 21 September. A close above Rs 662 would put Rs 677 in play, while a weekly close under Rs 640 would open a fresh 52-week low. The Q2 FY27 results are the main trigger. This range anchors the near-term Medplus Health Services share price target.
12-Month and 2027 Medplus Health Services Share Price Target
The 12-month target price is Rs 624 to Rs 744, valued on 26 to 31 times FY28 EPS of Rs 24. The range across scenarios runs from Rs 330 in the bear case to Rs 1,054 in the bull case.
Long-Term Medplus Health Services Share Price Target for FY29 to 2030
For FY29 to 2030 the Univest scenario range is Rs 744 to Rs 1,160. This assumes EPS of Rs 31 in FY29 and Rs 40 in FY30 and a multiple of 24 to 29 times. It needs older stores to keep growing, new stores to mature and margin to recover toward 5 percent. This is the long-term Medplus Health Services share price target in the Univest scenarios.
Bull Case and Bear Case for Medplus Health Services Share Price Target
Bull Case Rs 930 to Rs 1,054
The bull case of Rs 930 to Rs 1,054 for the Medplus Health Services share price target needs EPS of Rs 31 and the market to pay 30 to 34 times for it. It is +42.8% to +61.8% from the last close.
Bear Case Rs 330 to Rs 390
The bear case of Rs 330 to Rs 390 for the Medplus Health Services share price target equals 22 to 26 times FY28 EPS of Rs 15 and sits below the Rs 640.1 low. It is -49.3% to -40.1% from the last close.
Is Medplus Health Services a Good Buy at Rs 651? Medplus Health Services Buy or Sell View
Whether Medplus Health Services is a buy at Rs 651.45 depends on horizon and risk appetite. The base case sits between 4 percent below and 14 percent above the current price, the stock is 36 percent below its high, and the open question is margin. The Medplus Health Services share price target range is the starting point for that decision.
Long-term holders may focus on store growth, mature store margin and pricing, and treat Rs 640 as the level to watch. Short-term traders may prefer to wait for a close above Rs 662. Check institutional holding in the September quarter filing for signs of accumulation or selling. Consult a SEBI-registered advisor before acting, since this Medplus Health Services buy or sell view is educational.
How to Invest in Medplus Health Services Shares
Step 1: Check the live price, valuation and the latest Medplus Health Services share price target range on the Univest Screener.
Step 2: Open a demat and trading account with a SEBI-registered broker such as Univest before acting on any Medplus Health Services share price target.
Step 3: Search for MEDPLUS on the NSE or 543427 on the BSE in your trading app.
Step 4: Place a limit order near your planned entry and size the position so a fall to Rs 330 is bearable.
Step 5: Track store additions, margin and Q2 FY27 results and set price alerts on the Univest App to follow any change in the Medplus Health Services share price target.
Conclusion
Medplus Health Services closed at Rs 651.45 against a Univest base case share price target of Rs 624 to Rs 744, a bull case of Rs 930 to Rs 1,054 and a bear case of Rs 330 to Rs 390. Q1 FY27 delivered revenue growth of 21.8 percent but profit down 21.7 percent, with 5,476 stores. The main risks are margin pressure, cost inflation and a premium multiple.
The stock is 36.3 percent below its 52-week high, so the base case sits between 4 percent below and 14 percent above the current price. The triggers to watch are store additions, margin and Q2 FY27 results and the Rs 640 and Rs 662 levels. Re-check the Medplus Health Services share price target after each quarterly result. Investors with a long horizon and tolerance for volatility can track these triggers, while others may prefer to size positions carefully.
Download the Univest iOS App or Univest Android App to track Medplus Health Services live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Medplus Health Services Share Price Target 2026
What is the Medplus Health Services share price target for 2026?
Ans. The Medplus Health Services share price target for 2026 is Rs 624 to Rs 744 in the Univest base case, with a bull case of Rs 930 to Rs 1,054 and a bear case of Rs 330 to Rs 390. Nomura maintained a Buy rating on Medplus Health Services after the Q1 FY27 results, according to media reports, though the target price was not confirmed in the sources we track. These are estimates and can change after the Q2 FY27 results.
What is the Medplus Health Services share price target for 2027?
Ans. The Medplus Health Services share price target for 2027 is Rs 624 to Rs 744 in the base case, valued on 26 to 31 times FY28 EPS of Rs 24. The scenario range runs from Rs 330 to Rs 1,054.
Is Medplus Health Services a good buy at Rs 651.45?
Ans. Whether Medplus Health Services is a good buy at Rs 651.45 depends on your horizon, risk appetite and how you read the Medplus Health Services share price target. Revenue is growing 22 percent and the multiple is below the industry, but profit fell 22 percent and the stock sits at a 52-week low. Consult a SEBI-registered advisor before investing.
What are the key risks to the Medplus Health Services share price target?
Ans. The key risks to the Medplus Health Services share price target are margin pressure, cost inflation, slow private label growth and premium multiple. Operating EBITDA margin fell to 3.5 percent. More start-up costs from new stores would hold profit down.
What are the key catalysts for the Medplus Health Services share price target?
Ans. The key catalysts for the Medplus Health Services share price target are store growth, mature store margin, pricing and fee changes and franchise model. The chain targets 800 net new stores in FY27 after adding 146 in Q1. Stores over 12 months old generate 94 percent of pharmacy sales.
Where can I track Medplus Health Services share price today and Medplus Health Services share price target updates?
Ans. You can track the live Medplus Health Services share price, results and any change to the Medplus Health Services share price target on the Univest Screener and the Univest App. Download the Univest iOS App or Univest Android App for research from SEBI-registered analysts.
What are Medplus Health Services's 52-week high and low?
Ans. Medplus Health Services's 52-week high is Rs 1,022.20 and its 52-week low is Rs 640.10, based on weekly NSE data. At Rs 651.45 the stock is 36.3 percent below the high and 1.8 percent above the low. Both levels frame the Medplus Health Services share price target.
How to buy Medplus Health Services shares?
Ans. Open a demat account with a SEBI-registered broker such as Univest, search for MEDPLUS on the NSE or 543427 on the BSE, and place a limit order near your entry price, using the Medplus Health Services share price target range as a guide. Size the position so a fall to Rs 330 is bearable, and check the live price on the Univest Screener first.
Recent Articles
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
13 November 2026
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
13 November 2026
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
13 November 2026
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
13 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Stocks to Buy for 2027: Ventura's Samvat 2083 Picks Include HDFC Bank, Paytm, Meesho, Ather, LG Electronics India and Park Medi World, With Targets Up to 75% Above the Price at Publication
Microsoft Outage on 13 November 2026 Sends Traders Back to Phones and Fax: What the Outlook, Teams and Copilot Failure Means for Global Markets, Indian Brokerages and Investors
Ingersoll Rand Dividend of Rs 20 Per Share: Record Date 19 November 2026, Payout on 2 December and What the Q2 FY27 Profit Rise of 9% Says About the Payout and the Stock
Viceroy Hotels Share Price Gains Nearly 4% After Q2 FY27 Results: Revenue Up 56.5% to Rs 48.20 Crore but Profit Halves to Rs 2.23 Crore, and Why the Rs 106 Crore Rights Issue Matters on 13 November 2026
SC Agrotech Bonus Issue and Stock Split: 4:5 Bonus and 1:10 Split Proposed as the Stock Locks a 5% Upper Circuit at Rs 62.38, Q2 Profit Up 48 Times and What Shareholders Should Check Before the 11 December EGM
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times